Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$1.04B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$896M |
| 3 |
BHP
BHP
|
+$620M |
| 4 |
Amazon
AMZN
|
+$608M |
| 5 |
NVIDIA
NVDA
|
+$555M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$813M |
| 2 |
Walt Disney
DIS
|
+$667M |
| 3 |
Intel
INTC
|
+$658M |
| 4 |
UnitedHealth
UNH
|
+$649M |
| 5 |
Cisco
CSCO
|
+$646M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.43% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 9.96% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Communication Services | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
251
DELISTED
Cadence Bank
CADE
| $31.8M | 0.02% |
1,088,351
+288,802
| +36% | +$9.01M |
|
252
Veracyte
VCYT
$3.8B
| $31.7M | 0.02% |
1,148,219
-21,399
| -2% | -$612K |
|
253
Bristol-Myers Squibb
BMY
$132B
| $31.4M | 0.02% |
429,811
-13,132
| -3% | -$882K |
|
254
Marvell Technology
MRVL
$196B
| $30.4M | 0.02% |
423,726
+3,160
| +0.8% | +$228K |
|
255
Omnicell
OMCL
$1.68B
| $30.1M | 0.02% |
232,792
-11,021
| -5% | -$1.59M |
|
256
Glacier Bancorp
GBCI
$6.35B
| $30.1M | 0.02% |
598,008
+121,712
| +26% | +$6.57M |
|
|
PXD
257
DELISTED
Pioneer Natural Resource Co.
PXD
| $30M | 0.02% |
120,087
+13,809
| +13% | +$3.12M |
|
258
Lantheus
LNTH
$6.59B
| $29.5M | 0.02% |
533,275
+8,414
| +2% | +$316K |
|
259
Ecopetrol
EC
$34.5B
| $29.4M | 0.02% |
1,578,099
+660,298
| +72% | +$10.4M |
|
260
Wipro
WIT
$20B
| $29.3M | 0.02% |
7,606,336
+229,420
| +3% | +$904K |
|
261
WillScot Mobile Mini Holdings
WSC
$4.41B
| $28.7M | 0.02% |
732,796
-29,743
| -4% | -$1.12M |
|
262
AAR Corp
AIR
$5.76B
| $28.6M | 0.02% |
591,094
-21,038
| -3% | -$910K |
|
263
RLJ Lodging Trust
RLJ
$1.69B
| $28.6M | 0.02% |
2,030,920
-63,881
| -3% | -$898K |
|
264
Biogen
BIIB
$30.7B
| $27.9M | 0.02% |
132,344
+310
| +0.2% | +$67.4K |
|
265
Lowe's Companies
LOW
$125B
| $27.7M | 0.02% |
137,200
+373
| +0.3% | +$85.8K |
|
266
Core Laboratories
CLB
$521M
| $27.3M | 0.02% |
863,906
+26,827
| +3% | +$752K |
|
267
United Microelectronic
UMC
$46.9B
| $27M | 0.02% |
2,958,083
+2,822,983
| +2,090% | +$28M |
|
268
Canadian Pacific Kansas City
CP
$80.5B
| $26.6M | 0.02% |
322,011
+20,547
| +7% | +$1.55M |
|
269
Carpenter Technology
CRS
$28.4B
| $25.8M | 0.02% |
615,453
+84,370
| +16% | +$2.95M |
|
270
Oceaneering
OII
$4.77B
| $25.8M | 0.02% |
1,702,075
+4,367
| +0.3% | +$62.8K |
|
271
Diamondback Energy
FANG
$52.7B
| $25.8M | 0.02% |
188,207
+11,612
| +7% | +$1.51M |
|
272
Veeco
VECO
$3.23B
| $25.6M | 0.02% |
939,740
-16,498
| -2% | -$465K |
|
|
BPMC
273
DELISTED
Blueprint Medicines
BPMC
| $25.4M | 0.02% |
398,055
-2,218
| -0.6% | -$159K |
|
|
SWAV
274
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $25.4M | 0.02% |
122,260
+1,570
| +1% | +$259K |
|
275
UMB Financial
UMBF
$11.1B
| $24.5M | 0.01% |
251,749
+22,714
| +10% | +$2.32M |
|
Similar funds
Ken Fisher's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Fisher held 1,181 positions worth $169B, down 5.1% from $179B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher deployed $5.41B of net new capital in Q1 2022, opening 114 new positions and adding to 450 existing holdings. Its largest new stake was Shell: 19,596,216 shares worth $1.08B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $667M trimmed.
- Ken Fisher's largest Q1 2022 buy was Shell: 19,596,216 shares worth $1.08B.
- Ken Fisher added most to State Street SPDR Portfolio Long Term Treasury ETF in Q1 2022, an estimated $896M increase.
- Ken Fisher's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $667M.
- Ken Fisher fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $813M.
- Ken Fisher's ten largest holdings make up 31% of its $169B portfolio in Q1 2022.
- Ken Fisher opened 114 new positions and closed 95 in Q1 2022.
- Ken Fisher's portfolio value fell 5.1% quarter-over-quarter to $169B.
Based on Fisher Asset Management's 13F filing for Q1 2022, filed 5 May 2022.